Recursion Pharmaceuticals could benefit from FDA’s AI shift despite risks, with scalable tech and long-term potential. Find ...

Montage Gold is advancing its low-cost, long-life Koné project amid a secular gold bull market and rapid construction ...

Mesoblast Limited’s FDA-approved Ryoncil and advancing Revascor target major conditions like SR-aGVHD and heart failure. See ...

It remains to be seen how the new management team will lead Patriot National Bancorp. Click here to read why PNBK stock is a ...

The Bloomberg US Credit Index returned +2.36% for the quarter. A bull-steepening UST yield curve more than offset the ...

FFA offers a blend of capital appreciation and consistent income, with a 7.3% dividend yield. Click here to read why I rate ...

Nvidia faces competition from high-tech majors, risking market share and profit margins. Read why I remain neutral on NVDA ...

SNDL Inc. is considering different listing options to enhance its involvement in US cannabis markets. Read why I change my ...

Despite revised FY 2025 guidance due to tariff impacts, General Motors remains highly profitable with significant FCF. Read ...

Lumen Technologies pivots to AI infrastructure, reduces debt, and projects $3.5B+ EBITDA by 2026. Read why LUMN stock is a ...

Gorilla Technology has a large pipeline, with $2B in signed contracts and an additional $4.6B in potential deals. Read why a ...

Crude oil futures have dropped more than 3% Sunday after OPEC+ agreed to accelerate production increases for a second ...